PAYSNasdaqServices-Business Services, NECFiscal year ends December 31
Paysign, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$15.34+0.54 (+3.65%)
Close on Oct 19, 2026
- Market cap
- $950.70M
- P/E (TTM)
- 59.0
- Dividend yield
- –
Paysign, Inc. revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| Plasma Industry [Member] | $45.62M | $43.88M | $41.95M | $34.74M | $25.92M | $23.40M | $26.99M | $23.03M | 55.6% | +4.0% |
| Pharma Industry [Member] | $33.89M | $12.65M | $4.05M | – | – | – | – | – | 41.3% | +167.8% |
| Other Revenue [Member] | $2.52M | $1.85M | $1.27M | $288.89K | $184.83K | $392.67K | – | – | 3.1% | +36.2% |
| Breakage Revenue [Member] | $474.71K | $242.36K | – | – | – | – | – | – | 0.6% | +95.9% |
| Settlement Revenue [Member] | $0 | $30.00K | – | – | – | – | – | – | 0.0% | -100.0% |
| Pharmaceutical Industry [Member] | – | – | $4.05M | $3.01M | $3.36M | $326.70K | $7.37M | $366.44K | – | – |
| Other [Member] | – | – | – | – | – | $392.67K | $298.73K | $25.41K | – | – |
By region
From the segment and revenue-disaggregation notes of Paysign's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.